Thomas McGauley, Interim CFO of Tenax Therapeutics ($TENX), made three open market purchases of common shares totaling $58,164 in the last 365 days. His most recent buy occurred on November 17, 2025. These purchases rank 2,843rd among 4,983 individual insiders, well below the average of $1.46 million per buyer and 3.3 transactions. McGauley reported no open market sales during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 30, 2026 | TENAX THERAPEUTICS, INC. | $TENX | MCGAULEY THOMAS | Interim CFO | M | Stock Option (right to buy) | 50000 | $0.00 | 50,000.0000 | 39,741,404 | 9999.99% | 0.13% |
| Nov. 17, 2025 | TENAX THERAPEUTICS, INC. | $TENX | MCGAULEY THOMAS | Interim CFO | P | Common Stock | 2000 | $7.34 | 8,000.0000 | 39,741,404 | 33.33% | 0.01% |
| Nov. 17, 2025 | TENAX THERAPEUTICS, INC. | $TENX | MCGAULEY THOMAS | Interim CFO | P | Common Stock | 1000 | $7.35 | 8,000.0000 | 39,741,404 | 14.29% | 0.00% |
| Nov. 17, 2025 | TENAX THERAPEUTICS, INC. | $TENX | MCGAULEY THOMAS | Interim CFO | P | Common Stock | 5000 | $7.23 | 8,000.0000 | 39,741,404 | 166.67% | 0.01% |